Bexarotene Capsule
Product Images NDC 0832-0285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 0832-0285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bexarotene 01)

FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

Principal Display Panel (75 mg Capsule Bottle Label)
Bexarotene Capsules is a medication that is available in 75mg capsules and is only available with a prescription. Each capsule contains butylated hydroxyanisole, polyethylene glycol, polysorbate, povidone, gelatin, glycerin, sorbitol, titanium dioxide, and water. It is advisable to store the medication at a temperature range of 2° to 25°C and avoid exposing it to high temperatures and humidity after the bottle is opened. Additionally, the drug must be protected from light and stored in a place inaccessible to children. For more information, consult the accompanying patient information or full prescribing information. *

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.